Testosterone raised soft plaque growth by 41 mm3 in a 1-year RCT of older men
Louis covers a 2017 randomized trial by Matthew Budoff using CT angiography. Testosterone users had much more noncalcified plaque growth than placebo, compared with a typical ~5 mm3/year; TRT is beneficial only in true hypogonadism.